A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Determine the Effect of QVA149 on Mean 24-hours Heart Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD).
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2015
At a glance
- Drugs Glycopyrrolate/indacaterol (Primary) ; Indacaterol
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors Novartis
- 15 Mar 2012 This trial is recruiting in France, Spain.
- 08 Dec 2009 Planned number of patients changed from 250 to 257 as reported by ClinicalTrials.gov.
- 16 Sep 2009 Tolerability results were reported at the 19th Annual Congress of the European Respiratory Society.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History